IRIS
AIUTI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.080
EU - Europa 2.020
AS - Asia 707
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
AF - Africa 3
OC - Oceania 3
Totale 13.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.070
DE - Germania 828
SG - Singapore 370
CN - Cina 226
UA - Ucraina 221
IT - Italia 206
RU - Federazione Russa 184
GB - Regno Unito 180
IE - Irlanda 177
SE - Svezia 79
FI - Finlandia 49
FR - Francia 46
KR - Corea 43
BE - Belgio 17
IN - India 11
VN - Vietnam 10
CA - Canada 8
HK - Hong Kong 8
JP - Giappone 7
KG - Kirghizistan 7
NL - Olanda 7
TR - Turchia 7
IR - Iran 6
ES - Italia 4
EU - Europa 4
AT - Austria 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
IL - Israele 3
PL - Polonia 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AU - Australia 2
EG - Egitto 2
GR - Grecia 2
MX - Messico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BG - Bulgaria 1
BR - Brasile 1
BY - Bielorussia 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
ID - Indonesia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
TW - Taiwan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 13.823
Salva come PNG Salva come JPEG
Città #
Wilmington 2.637
Woodbridge 2.636
Houston 2.476
Fairfield 639
Ann Arbor 391
Singapore 328
Ashburn 277
Chandler 268
Seattle 242
Cambridge 201
Jacksonville 195
Dublin 164
Medford 128
Dearborn 92
Santa Clara 92
Beijing 91
Rome 62
Lawrence 53
Menlo Park 41
Zhengzhou 33
New York 32
San Diego 31
Mülheim 22
Falls Church 19
Munich 17
Brussels 16
Milan 15
Moscow 15
Nanjing 15
Hefei 14
Redwood City 14
Boardman 12
San Mateo 12
Norwalk 11
University Park 11
Shanghai 10
Dong Ket 9
Phoenix 9
London 8
Toronto 8
Verona 8
Mountain View 7
Engelhard 6
Jinan 6
Kunming 6
Council Bluffs 5
Florence 5
Hangzhou 5
Lappeenranta 5
Los Angeles 5
Amsterdam 4
Center 4
Hong Kong 4
Kilburn 4
Nuremberg 4
Redmond 4
St. George 4
Ankara 3
Brno 3
Central District 3
Chiswick 3
Codogno 3
Creede 3
Dallas 3
Detroit 3
Guangzhou 3
Helsinki 3
Hounslow 3
Islington 3
Pune 3
Seoul 3
Shenzhen 3
Washington 3
Ardabil 2
Auburn Hills 2
Augusta 2
Burbank 2
Casalecchio di Reno 2
Delhi 2
Fuzhou 2
Garbagnate Milanese 2
Hebei 2
Indiana 2
Konak 2
Kyiv 2
Mexico City 2
Monte Vista 2
Mount Washington 2
Nanchang 2
Nanning 2
New Bedfont 2
Nürnberg 2
Paderno Dugnano 2
Padova 2
Pontecchio Polesine 2
Portici 2
Saint Petersburg 2
San Giovanni in Persiceto 2
Shenyang 2
Suceava 2
Totale 11.534
Salva come PNG Salva come JPEG
Nome #
Longitudinal Evaluation of Immune Reconstitution and B-cell Function After Hematopoietic Cell Transplantation for Primary Immunodeficiency 443
Chronic Granulomatous Disease Presenting with Salmonella Brain Abscesses. 440
Gene therapy for immunodeficiency due to adenosine deaminase deficiency 440
Clinical features and follow-up in patients with 22q11.2 deletion syndrome 438
Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis 430
Early-onset monocyte-B-natural killer-dendritic cells' deficiency successfully treated with hematopoietic stem cell transplantation. 421
The Quality of Life of Children and Adolescents with X-Linked Agammaglobulinemia 421
Etiology, clinical outcome, and laboratory features in children with neutropenia: analysis of 104 cases 417
Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID 412
In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency. 410
The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function 409
Autoimmunity and regulatory T cells in 22q11.2 deletion syndrome patients 407
Lentiviral Hematopoietic Stem Cell Gene Therapy in Patients with Wiskott-Aldrich Syndrome. 400
. Early-onset monocyte-B-natural killer-dendritic cells’ deficiency successfully treated with hematopoietic stem cell transaplantation 391
Successful treatment with percutaneous transhepatic alcoholization of a liver abscess in a child with chronic granulomatous disease 383
Defective B-cell proliferation and maintenance of long-term memory in patients with chronic granulomatous disease 378
Long-Term Safety and Efficacy of Gene Therapyfor Adenosine Deaminase (ADA)-Deficient Severe Combined Immunodeficiency 375
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 368
Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome) 368
Clinical features and follow-up in patients with 22q11.2 deletion syndrome 357
Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency 332
null 316
Targeted NGS platforms for genetic screening and gene discovery in primary immunodeficiencies 248
Targeted NGS Platforms for Genetic Screening and Gene Discovery in Primary Immunodeficiencies. Front Immunol. 2019 Apr 11;10:316. doi: 10.3389/fimmu.2019.00316. eCollection 2019. Erratum in: Front Immunol. 2019 May 31;10:1184. 246
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy 181
Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: Analysis of function and distribution in lymphoid organs 180
JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene 179
Impaired X-CGD T cell compartment is gp91phox-NADPH oxidase independent 175
First Case of Patient With Two Homozygous Mutations in MYD88 and CARD9 Genes Presenting With Pyogenic Bacterial Infections, Elevated IgE, and Persistent EBV Viremia 165
ADA-deficient SCID is associated with a specific microenvironment and bone phenotype characterized by RANKL/OPG imbalance and osteoblast insufficiency 164
The case of an APDS patient: Defects in maturation and function and decreased in vitro anti-mycobacterial activity in the myeloid compartment 164
How I treat ADA deficiency 156
Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy 145
Large Deletion of MAGT1 Gene in a Patient with Classic Kaposi Sarcoma, CD4 Lymphopenia, and EBV Infection 144
Comprehensive genomic access to vector integration in clinical gene therapy. 142
Hematopoietic stem cell gene therapy for adenosine deaminase deficient-SCID 141
Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. 139
Health-Related Quality of Life and Emotional Difficulties in Chronic Granulomatous Disease: Data on Adult and Pediatric Patients from Italian Network for Primary Immunodeficiency (IPINet) 139
Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID 137
A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function 137
Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy 134
Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models 130
Dendritic cell functional improvement in a preclinical model of lentiviral-mediated gene therapy for Wiskott-Aldrich syndrome 127
Gene therapy for adenosine deaminase deficiency. 125
Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency 125
Gene therapy for primary immunodeficiencies: Part 1 122
Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell. 121
Consensus of the Italian Primary Immunodeficiency Network on transition management from pediatric to adult care in patients affected with childhood-onset inborn errors of immunity 118
Update on gene therapy for adenosine deaminase-deficient severe combined immunodeficiency. 115
Gene therapy for primary immunodeficiencies: Part 2 115
Retroviral integrations in gene therapy trials 115
A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis 112
New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapy. 106
Ten years of gene therapy for primary immuno deficiencies 84
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999-2019) 81
Severe Toxoplasma gondii infection in a member of a NFKB2-deficient family with T and B cell dysfunction 63
X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 50
SARS-CoV-2 infection and treatment in a cohort of patients with inborn errors of immunity 47
SARS-CoV-2-related MIS-C: a key to the viral and genetic causes of Kawasaki disease? 43
Autoantibodies against type I IFNs in patients with life-threatening COVID-19 40
Natural history of Ras-associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progression 35
Radiosensitivity in patients affected by ARPC1B deficiency: a new disease trait? 33
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 32
Harnessing type I IFN immunity against SARS-CoV-2 with early administration of IFN-β 31
The Inborn Errors of Immunity—Virtual Consultation System Platform in Service for the Italian Primary Immunodeficiency Network: Results from the Validation Phase 28
A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis 22
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection 21
From your nose to your toes: a review of severe acute respiratory syndrome Coronavirus 2 pandemic‒associated pernio 19
Studying severe long COVID to understand post-infectious disorders beyond COVID-19 16
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19 11
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 11
A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for ADA-SCID 9
Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity 7
A Novel Assay in Whole Blood Demonstrates Restoration of Mitochondrial Activity in Phagocytes After Successful HSCT in Hyperinflamed X-Linked Chronic Granulomatous Disease 7
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency 6
Totale 13.999
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.526
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.526
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.516 0 0 0 0 277 352 358 344 399 327 207 252
2020/20212.434 223 276 209 330 286 224 293 250 99 87 110 47
2021/2022678 22 72 29 35 43 49 32 46 84 46 37 183
2022/2023767 86 59 28 86 56 186 74 43 64 10 54 21
2023/2024292 34 27 20 14 37 64 13 20 12 0 7 44
2024/2025737 54 376 162 98 47 0 0 0 0 0 0 0
Totale 13.999